PRPO on Nasdaq
Precipio, Inc.
American laboratory analytical instruments company based in New Haven.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with BioNano Genomics, EyePoint Pharmaceuticals or RAPID MICRO BIOSYSTEMS, INC., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Service revenue, net brought in 89% of the revenue Precipio, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Service revenue, net | $16.0M | $21.5M |
| Product | $2.6M | $2.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue55¢$13.3M
- Research and development7¢$1.6M
- Other costs38¢$9.3M
Out of $24.2M in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending48¢$326.0K
- Kept or used elsewhere52¢$359.0K
Out of $685.0K of cash from operations.3
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue, net of contractual allowances and adjustments | $24.2M | $18.6M |
| Adjustment for allowance for credit losses | -$197.0K | -$44.0K |
| Net sales | $24.0M | $18.5M |
| Total cost of sales | $13.3M | $11.0M |
| Gross profit | $10.7M | $7.6M |
| Operating expenses | $11.9M | $11.8M |
| OPERATING LOSS | -$1.2M | -$4.2M |
| Interest expense, net | -$73.0K | -$74.0K |
| Gain on settlement of liability | $143.0K | |
| Employee Retention Credit | $789.0K | |
| Other expense | -$20.0K | |
| Total other income (expense) | $839.0K | -$74.0K |
| LOSS BEFORE INCOME TAXES | -$363.0K | -$4.3M |
| INCOME TAX EXPENSE | $0 | $0 |
| NET LOSS | -$363.0K | -$4.3M |
| BASIC LOSS PER COMMON SHARE | -$0.23 | -$2.93 |
| BASIC WEIGHTED-AVERAGE SHARES OF COMMON STOCK OUTSTANDING | 1.6M shares | 1.5M shares |
| DILUTED LOSS PER COMMON SHARE | -$0.23 | -$2.93 |
| DILUTED WEIGHTED-AVERAGE SHARES OF COMMON STOCK OUTSTANDING | 1.6M shares | 1.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2018-12-31 |
|---|---|---|---|
| Cash | $2.7M | $1.4M | |
| Accounts receivable (net of allowance for credit losses of $1,045 and $995, respectively) | $2.0M | $799.0K | |
| Inventories | $935.0K | $724.0K | |
| Other current assets | $469.0K | $539.0K | |
| Total current assets | $6.0M | $3.5M | |
| PROPERTY AND EQUIPMENT, NET | $729.0K | $719.0K | |
| Finance lease right-of-use assets, net | $998.0K | $517.0K | |
| Operating lease right-of-use assets, net | $2.6M | $395.0K | |
| Intangibles, net | $10.9M | $11.9M | |
| Other assets | $67.0K | $45.0K | |
| Total assets | $21.3M | $17.0M | |
| Current maturities of long-term debt, less debt issuance costs | $30.0K | $297.0K | |
| Current maturities of finance lease liabilities | $209.0K | $124.0K | |
| Current maturities of operating lease liabilities | $410.0K | $201.0K | |
| Accounts payable | $1.1M | $618.0K | |
| Accrued expenses | $1.7M | $2.8M | |
| Deferred revenue | $282.0K | $232.0K | |
| Total current liabilities | $3.8M | $4.3M | |
| Long-term debt, less current maturities and debt issuance costs | $47.0K | $77.0K | |
| Finance lease liabilities, less current maturities | $751.0K | $348.0K | |
| Operating lease liabilities, less current maturities | $2.2M | $206.0K | |
| Total liabilities | $6.8M | $4.9M | |
| Common stock, $0.01 par value, 150,000,000 shares authorized at December 31, 2025 and December 31, 2024, 1,780,899 and 1,493,639 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $18.0K | $15.0K | |
| Additional paid-in capital | $117.3M | $114.5M | |
| Accumulated deficit | -$102.8M | -$102.4M | |
| Total stockholders' equity | $14.6M | $12.1M | |
| Total liabilities and stockholders' equity | $21.3M | $17.0M | |
| Allowance for credit losses | $1.0M | $995.0K | |
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Preferred stock, shares authorized (in shares) | 15.0M shares | 15.0M shares | |
| Preferred stock, shares issued (in shares) | 47 shares | 47 shares | |
| Preferred stock, shares outstanding (in shares) | 47 shares | 47 shares | |
| Preferred stock, liquidation preference | $135.0K | ||
| Common stock, par value (in $ per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 150.0M shares | 150.0M shares | 250.0M shares |
| Common stock, shares issued (in shares) | 1.8M shares | 1.5M shares | |
| Common stock, shares outstanding (in shares) | 1.8M shares | 1.5M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2018-12-31 |
|---|---|---|---|
| Cash | $2.7M | $1.4M | |
| Accounts receivable (net of allowance for credit losses of $1,045 and $995, respectively) | $2.0M | $799.0K | |
| Inventories | $935.0K | $724.0K | |
| Other current assets | $469.0K | $539.0K | |
| Total current assets | $6.0M | $3.5M | |
| PROPERTY AND EQUIPMENT, NET | $729.0K | $719.0K | |
| Finance lease right-of-use assets, net | $998.0K | $517.0K | |
| Operating lease right-of-use assets, net | $2.6M | $395.0K | |
| Intangibles, net | $10.9M | $11.9M | |
| Other assets | $67.0K | $45.0K | |
| Total assets | $21.3M | $17.0M | |
| Current maturities of long-term debt, less debt issuance costs | $30.0K | $297.0K | |
| Current maturities of finance lease liabilities | $209.0K | $124.0K | |
| Current maturities of operating lease liabilities | $410.0K | $201.0K | |
| Accounts payable | $1.1M | $618.0K | |
| Accrued expenses | $1.7M | $2.8M | |
| Deferred revenue | $282.0K | $232.0K | |
| Total current liabilities | $3.8M | $4.3M | |
| Long-term debt, less current maturities and debt issuance costs | $47.0K | $77.0K | |
| Finance lease liabilities, less current maturities | $751.0K | $348.0K | |
| Operating lease liabilities, less current maturities | $2.2M | $206.0K | |
| Total liabilities | $6.8M | $4.9M | |
| Common stock, $0.01 par value, 150,000,000 shares authorized at December 31, 2025 and December 31, 2024, 1,780,899 and 1,493,639 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $18.0K | $15.0K | |
| Additional paid-in capital | $117.3M | $114.5M | |
| Accumulated deficit | -$102.8M | -$102.4M | |
| Total stockholders' equity | $14.6M | $12.1M | |
| Total liabilities and stockholders' equity | $21.3M | $17.0M | |
| Allowance for credit losses | $1.0M | $995.0K | |
| Preferred stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Preferred stock, shares authorized (in shares) | 15.0M shares | 15.0M shares | |
| Preferred stock, shares issued (in shares) | 47 shares | 47 shares | |
| Preferred stock, shares outstanding (in shares) | 47 shares | 47 shares | |
| Preferred stock, liquidation preference | $135.0K | ||
| Common stock, par value (in $ per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 150.0M shares | 150.0M shares | 250.0M shares |
| Common stock, shares issued (in shares) | 1.8M shares | 1.5M shares | |
| Common stock, shares outstanding (in shares) | 1.8M shares | 1.5M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$363.0K | -$4.3M |
| Depreciation and amortization | $1.2M | $1.2M |
| Amortization of operating lease right-of-use asset | $319.0K | $217.0K |
| Amortization of finance lease right-of-use asset | $188.0K | $97.0K |
| Amortization of deferred financing costs, debt discounts and debt premiums | $3.0K | $3.0K |
| Gain on settlement of liability | -$143.0K | |
| Stock-based compensation | $1.2M | $1.5M |
| Value of stock issued in payment of Board fees and consulting services | $241.0K | $386.0K |
| Provision for credit losses | $177.0K | $64.0K |
| Derecognition of finance lease right-of-use asset and liability | -$4.0K | $2.0K |
| Derecognition of operating lease right-of-use asset and liability | -$38.0K | |
| Loss on disposal of asset | $20.0K | |
| Accounts receivable | -$1.4M | $438.0K |
| Inventories | -$211.0K | -$340.0K |
| Other assets | $48.0K | $303.0K |
| Accounts payable | $513.0K | -$10.0K |
| Operating lease liabilities | -$241.0K | -$218.0K |
| Deferred revenue | $50.0K | $122.0K |
| Accrued expenses | -$966.0K | $975.0K |
| Net cash provided by operating activities | $685.0K | $439.0K |
| Purchase of property and equipment | -$326.0K | -$223.0K |
| Net cash used in investing activities | -$326.0K | -$223.0K |
| Principal payments on finance lease obligations | -$157.0K | -$92.0K |
| Deposits on finance lease right-of-use assets | -$20.0K | -$28.0K |
| Issuance of common stock, net of issuance costs | $78.0K | |
| Proceeds from exercise of warrants | $1.3M | |
| Proceeds from exercise of stock options | $119.0K | |
| Proceeds from debt | $250.0K | |
| Principal payments on long-term debt | -$300.0K | -$537.0K |
| Net cash flows provided by (used in) financing activities | $903.0K | -$329.0K |
| NET CHANGE IN CASH | $1.3M | -$113.0K |
| Cash paid during the period for interest | $100.0K | $85.0K |
| Purchases of equipment financed through accounts payable | $6.0K | |
| Prepaid insurance financed with loan | $317.0K | |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations | $2.5M | $0 |
| Finance lease right-of-use assets obtained in exchange for finance lease obligations | $649.0K | $414.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Precipio, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerIlan Danieli Jul 3, 2017 to now12
- Chief executive officerPaul Kinnon Oct 3, 2013 to Apr 3, 201513
- Chief executive officerCraig James Tuttle Jul 13, 2006 to May 7, 201314
- PresidentPaul Kinnon Oct 3, 2013 to Apr 3, 201513
- PresidentCraig James Tuttle Jul 13, 2006 to May 7, 201314
- Chief financial officerMatthew Gage Mar 30, 2022 to now15
- Chief financial officerIlan Danieli Jan 5, 2021 to Jan 13, 202216
- Chief financial officerCarl Iberger Jul 10, 2017 to Jan 13, 202217
- Chief financial officerPaul Kinnon Apr 3, 2015 to Apr 3, 201518
- Chief financial officerMark P. Colonnese Sep 17, 2012 to Feb 20, 201419
- Chief financial officerBrett L. Frevert Sep 9, 2010 to Jun 7, 201120
- Chief financial officerDebra A. Schneider Dec 5, 2006 to Dec 7, 200721
- Chief operating officerAhmed Zaki Sabet Sep 3, 2020 to now22
Board members and other officers (28)
- See RemarkMatthew Gage Jan 10, 2023 to Jan 10, 202323
- Chief Operations OfficerAhmed Zaki Sabet Dec 5, 2019 to Jul 14, 202024
- Chief Accounting OfficerLeon Richards Nov 5, 2014 to Apr 3, 201525
- Senior VP, Sales & MarketingChad M. Richards Sep 9, 2010 to Jun 25, 201226
- Chief Scientific OfficerEric P. Kaldjian May 22, 2008 to Feb 9, 200927
- Board memberChristina Rizopoulos Valauri Jan 4, 2024 to now28
- Board memberRonald Asbury Andrews Mar 4, 2021 to now29
- Board memberRichard A. Sandberg Dec 4, 2019 to now30
- Board memberKathleen Laporte Aug 13, 2018 to now31
- Board memberIlan Danieli Jul 3, 2017 to now12
- Board memberMark Rimer Jul 3, 2017 to Jan 13, 202232
- Board memberSamuel D. Riccitelli Jul 10, 2017 to Mar 20, 201933
- Board memberJeffrey Cossman Sep 28, 2017 to now34
- Board memberMya Thomae Jun 10, 2015 to Dec 15, 201635
- Board memberMichael A. Luther Mar 19, 2014 to Feb 21, 201836
- Board memberCraig James Tuttle May 7, 2013 to May 7, 201337
- Board memberPaul Kinnon Oct 3, 2013 to Apr 3, 201513
- Board memberDoit Koppler Ii. Jan 10, 2011 to Dec 15, 201638
- Board memberRobert Patzig Jan 10, 2011 to Sep 28, 201739
- Board memberAntonius Schuh Jun 2, 2009 to Feb 20, 201440
- Board memberMichael B. McNulty Jun 2, 2009 to Jun 11, 201041
- Board memberDavid P. Pauluzzi Jan 2, 2008 to Apr 2, 200842
- Board memberRodney S. Markin Mar 15, 2007 to Feb 20, 201443
- Board memberGregory J. Duman Sep 5, 2006 to Dec 16, 200844
- Board memberGregory T. Sloma Sep 5, 2006 to Jun 11, 201045
- Board memberJeffrey L. Sklar Sep 5, 2006 to Jun 11, 201046
- Board memberParag Saxena Sep 5, 2006 to Sep 11, 200647
- Board memberRoland J. Santoni Sep 5, 2006 to Nov 21, 200648
Former names
- TRANSGENOMIC INCMar 10, 2000 to Jun 30, 20172
Timeline
Filings
250 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 50 major events, 138 insider forms, 4 large holders, 38 other. The latest 20:
- Aug 14, 20268-K EDGAR
- Aug 14, 202610-Q EDGAR
- Jul 31, 20268-K EDGAR
- Jul 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 15, 20268-K EDGAR
- May 26, 20264 OWNERSHIP DOCUMENT EDGAR
- May 21, 20264 OWNERSHIP DOCUMENT EDGAR
- May 19, 2026144 EDGAR
- May 14, 202610-Q EDGAR
- May 6, 20268-K EDGAR
- Apr 28, 2026ARS EDGAR
- Apr 28, 2026DEFA14A EDGAR
- Apr 28, 2026DEF 14A EDGAR
- Apr 17, 20264 OWNERSHIP DOCUMENT EDGAR
- Apr 17, 20264 OWNERSHIP DOCUMENT EDGAR
- Apr 17, 20264 OWNERSHIP DOCUMENT EDGAR
- Apr 10, 20264 OWNERSHIP DOCUMENT EDGAR
- Mar 30, 202610-K EDGAR
The 250 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 4 such filings since October 2021:
- Feb 10, 2026SCHEDULE 13G/A
- Oct 21, 2025SCHEDULE 13G/A
- Sep 22, 2025SCHEDULE 13G
- Aug 2, 2024SC 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 46,148 | $1.1M | 0.0% | +20,665 |
| BlackRock, Inc. | 34,655 | $858.1K | 0.0% | +5,633 |
| Geode Capital Management, LLC | 18,691 | $462.9K | 0.0% | −120 |
| Renaissance Technologies LLC | 16,199 | $401.1K | 0.0% | −3,101 |
| Citadel Advisors LLC | 14,714 | $364.3K | 0.0% | −402 |
| XTX Topco Ltd | 9,450 | $234.0K | 0.0% | New |
| Vanguard Fiduciary Trust Co | 9,407 | $232.9K | 0.0% | +62 |
| Dimensional Fund Advisors LP | 8,396 | $207.9K | 0.0% | New |
| UBS Group AG | 343 | $8.5K | 0.0% | +116 |
| Wells Fargo & Company/mn | 50 | $1.2K | 0.0% | No change |
| Tower Research Capital LLC (TRC) | 32 | $792 | 0.0% | −106 |
| Morgan Stanley | 7 | $173 | 0.0% | New |
| Allworth Financial LP | 3 | $75 | 0.0% | No change |
| IFP Advisors, Inc | 3 | $74 | 0.0% | No change |
| Fmr LLC | 2 | $54 | 0.0% | No change |
| Citigroup Inc | 1 | $25 | 0.0% | New |
| Caitong International Asset Management Co., Ltd | 1 | $25 | 0.0% | New |
| Royal Bank Of Canada | 11 | $0 | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPrecipio, Inc. filings on SEC EDGAR
- 2SEC EDGARPrecipio, Inc. filings on SEC EDGAR
- 3SEC EDGARPrecipio, Inc. 10-K for fiscal 2025
- 4SEC EDGARPrecipio, Inc. 10-K for fiscal 2019
- 5SEC EDGARPrecipio, Inc. 10-K for fiscal 2020
- 6SEC EDGARPrecipio, Inc. 10-K for fiscal 2021
- 7SEC EDGARPrecipio, Inc. 10-K for fiscal 2022
- 8SEC EDGARPrecipio, Inc. 10-K for fiscal 2023
- 9SEC EDGARPrecipio, Inc. 10-K for fiscal 2019
- 10SEC EDGARPrecipio, Inc. 10-Q for fiscal 2026
- 11SEC EDGARPrecipio, Inc. 10-Q for fiscal 2026
- 12
- 13SEC EDGARPaul Kinnon, Chief executive officer
- 14
- 15
- 16
- 17
- 18SEC EDGARPaul Kinnon, Chief financial officer
- 19
- 20
- 21
- 22
- 23SEC EDGARMatthew Gage, See Remark
- 24
- 25
- 26
- 27
- 28
- 29SEC EDGARRonald Asbury Andrews, Board member
- 30SEC EDGARRichard A. Sandberg, Board member
- 31SEC EDGARKathleen Laporte, Board member
- 32SEC EDGARMark Rimer, Board member
- 33SEC EDGARSamuel D. Riccitelli, Board member
- 34SEC EDGARJeffrey Cossman, Board member
- 35SEC EDGARMya Thomae, Board member
- 36SEC EDGARMichael A. Luther, Board member
- 37SEC EDGARCraig James Tuttle, Board member
- 38SEC EDGARDoit Koppler Ii., Board member
- 39SEC EDGARRobert Patzig, Board member
- 40SEC EDGARAntonius Schuh, Board member
- 41SEC EDGARMichael B. McNulty, Board member
- 42SEC EDGARDavid P. Pauluzzi, Board member
- 43SEC EDGARRodney S. Markin, Board member
- 44SEC EDGARGregory J. Duman, Board member
- 45SEC EDGARGregory T. Sloma, Board member
- 46SEC EDGARJeffrey L. Sklar, Board member
- 47SEC EDGARParag Saxena, Board member
- 48SEC EDGARRoland J. Santoni, Board member
- 49